AbstractHIV-1 envelope glycoproteins (Env) and Env-based immunogens usually do not interact efficiently with the inferred germline precursors of known broadly neutralizing antibodies (bNAbs). This deficiency may be one reason why Env and Env-based immunogens are not efficient at inducing bNAbs. We evaluated the binding of 15 inferred germline precursors of bNAbs directed to different epitope clusters to three soluble native-like SOSIP.664 Env trimers. We found that native-like SOSIP.664 trimers bind to some inferred germline precursors of bNAbs, particularly ones involving the V1/V2 loops at the apex of the trimer. The data imply that native-like SOSIP.664 trimers will be an appropriate platform for structure-guided design improvements inte...
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccinati...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
HIV-1 envelope glycoproteins (Env) and Env-based immunogens usually do not interact efficiently with...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
Background: The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the target...
Broadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) trimer ...
Broadly neutralizing antibodies (bnAbs) against human immunodeficiency virus (HIV)-1 are rare in nat...
Broadly neutralizing antibodies (bnAbs) against HIV are believed to be a critical component of the p...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
SummaryBroadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) ...
Broadly neutralizing antibodies (bnAbs) against HIV are believed to be a critical component of the p...
Broadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) trimer ...
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccinati...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
HIV-1 envelope glycoproteins (Env) and Env-based immunogens usually do not interact efficiently with...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
Background: The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the target...
Broadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) trimer ...
Broadly neutralizing antibodies (bnAbs) against human immunodeficiency virus (HIV)-1 are rare in nat...
Broadly neutralizing antibodies (bnAbs) against HIV are believed to be a critical component of the p...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
SummaryBroadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) ...
Broadly neutralizing antibodies (bnAbs) against HIV are believed to be a critical component of the p...
Broadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) trimer ...
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccinati...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...